Profound Medical (PROF) announced that it has entered into an exclusive distribution and supply agreement for its TULSA-PRO system with Getz Healthcare, a leading distributor of medical devices, equipment and consumables, in Australia and New Zealand. “Like in many other regions around the globe, prostate cancer is the most commonly diagnosed cancer in men in Australasia,” said Arun Menawat, Profound’s CEO and Chairman. “We are excited to gain access to this significant market for TULSA-PRO. Beyond Australia and New Zealand, we are actively pursuing other potential opportunities to expand our strategic commercial partnership with Getz Healthcare to include additional key markets across Asia Pacific.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PROF:
- Profound Medical Expands into Saudi Arabia with Exclusive Distribution Agreement
- Profound Medical (PRN) Q3 Earnings Cheat Sheet
- Profound Medical Reclaims Canadian Distribution Rights for TULSA-PRO®
- Profound Medical regains exclusive distribution rights for Tulsa-Pro in Canada
- Profound Medical Celebrates 500th TULSA Procedure Milestone at Busch Center